CLGNAnnouncement•prnewswire•
CollPlant to Present at the 2025 International Conference on Biofabrication
Sentiment:Negative (30)
Summary
(NASDAQ:CLGN) REHOVOT, Israel, Sept. 2, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen), today announced its participation...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 2, 2025 by prnewswire